Literature DB >> 32620467

Role of Nrf2 in rheumatoid arthritis.

Swati Chadha1, Tapan Behl2, Arun Kumar1, Gaurav Khullar1, Sandeep Arora1.   

Abstract

BACKGROUND: Rheumatoid arthritis comprises the roots of 19th century and is an autoimmune and chronic inflammatory disorder leading to progressive joint destruction. This erosive joint damage is linked with infiltration of leukocytes along with inflammatory destruction and blood cell formation within the synovial membrane, deprivation of cartilage and bone that leads to incapacitative pain. The changes in synovium include its proliferation that leads to pannus formation and this ultimately leads to the invasion and erosions causing the destruction of joints. It is also defined as the destructive or chronic disease with a longer time duration that takes articular consideration as a feature.
OBJECTIVE: The factors that can lead to RA includes inflammatory cascades, increased levels of (TNF-α) tumor necrosis factor α, IL-1b and IL-17 (interleukins) along with reduced levels of Nrf2 factors (nuclear factor-erythroid 2-related factor-2). Nrf2 binds effectively to antioxidant response elements (ARE) that mainly encodes majority of the phase II antioxidant enzymes as well as stress receptive proteins including glutathione S-transferase (GSH), heme oxygenase-1 (HO-1), peroxiredoxin I, all these act by cellular defense mechanism and removes the cytotoxic electrophiles along with the ROS that is reactive oxygen species. Nrf2 also responds to the inflammatory stimulus and protect the tissues from the inflammatory tissues.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chronic destruction; Inflammation; Keap 1; Nrf2; Rheumatoid arthritis

Year:  2020        PMID: 32620467     DOI: 10.1016/j.retram.2020.05.002

Source DB:  PubMed          Journal:  Curr Res Transl Med        ISSN: 2452-3186            Impact factor:   4.513


  9 in total

Review 1.  Microbiota-assisted therapy for systemic inflammatory arthritis: advances and mechanistic insights.

Authors:  Bowen Li; Bo Yang; Xiaoming Liu; Jianxin Zhao; R Paul Ross; Catherine Stanton; Hao Zhang; Wei Chen
Journal:  Cell Mol Life Sci       Date:  2022-08-06       Impact factor: 9.207

Review 2.  Exploring the pivotal role of endothelin in rheumatoid arthritis.

Authors:  Aayush Sehgal; Tapan Behl; Sukhbir Singh; Neelam Sharma; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Lotfi Aleya; Aditi Sharma; Simona Bungau
Journal:  Inflammopharmacology       Date:  2022-08-27       Impact factor: 5.093

Review 3.  Organokines in Rheumatoid Arthritis: A Critical Review.

Authors:  Lucas Fornari Laurindo; Mariana Canevari de Maio; Sandra Maria Barbalho; Elen Landgraf Guiguer; Adriano Cressoni Araújo; Ricardo de Alvares Goulart; Uri Adrian Prync Flato; Edgar Baldi Júnior; Cláudia Rucco Penteado Detregiachi; Jesselina Francisco Dos Santos Haber; Patrícia C Santos Bueno; Raul S J Girio; Rachel Gomes Eleutério; Marcelo Dib Bechara
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

Review 4.  Exploring the role of cathepsin in rheumatoid arthritis.

Authors:  Tapan Behl; Swati Chadha; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Rajwinder Kaur; Saurabh Bhatia; Ahmed Al-Harrasi; Sridevi Chigurupati; Ahmed Alhowail; Simona Bungau
Journal:  Saudi J Biol Sci       Date:  2021-09-13       Impact factor: 4.219

5.  Medicarpin Increases Antioxidant Genes by Inducing NRF2 Transcriptional Level in HeLa Cells.

Authors:  Jung-Hwan Kim; Dong-Min Kang; Young-Jin Cho; Jin-Won Hyun; Mi-Jeong Ahn
Journal:  Antioxidants (Basel)       Date:  2022-02-18

Review 6.  Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy.

Authors:  Ting Zhao; Qi Yang; Yujiang Xi; Zhaohu Xie; Jiayan Shen; Zhenmin Li; Zhaofu Li; Dongdong Qin
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

Review 7.  Natural medicines of targeted rheumatoid arthritis and its action mechanism.

Authors:  Xueling Liu; Zhiguo Wang; Hua Qian; Wenhua Tao; Ying Zhang; Chunyan Hu; Weiwei Mao; Qi Guo
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 8.  Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases.

Authors:  Zhenzhen Zhai; Yanxin Huang; Yawei Zhang; Lili Zhao; Wen Li
Journal:  Antioxidants (Basel)       Date:  2022-08-12

Review 9.  Advancement in understanding the role of ferroptosis in rheumatoid arthritis.

Authors:  Li Long; Hongmei Guo; Xixi Chen; Yan Liu; Ruyi Wang; Xiaomei Zheng; Xiaobo Huang; Qiao Zhou; Yi Wang
Journal:  Front Physiol       Date:  2022-10-04       Impact factor: 4.755

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.